Feasibility and pharmacokinetic study of infusional dexrazoxane and dose-intensive doxorubicin administered concurrently over 96 h for the treatment of advanced malignancies

Author： Chow Warren   Synold Timothy   Tetef Merry   Longmate Jeffrey   Frankel Paul   Lawrence Joyce   Al-Khadimi Zaid   Leong Lucille   Lim Dean   Margolin Kim   Morgan Robert   Raschko James   Shibata Stephen   Somlo George   Twardowski Przemyslaw   Yen Yun   Doroshow James  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.54, Iss.3, 2004-09, pp. : 241-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Dose-intensive first-line chemotherapy with epirubicin and continuous infusion ifosfamide in adult patients with advanced soft tissue sarcomas: a phase II study

By Palumbo R.   Neumaier C.   Cosso M.   Bertero G.   Raffo P.   Spadini N.   Valente S.   Villani G.   Pastorino M.   Toma S.  

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 66-72

Elsevier

Access to resources Recommend Favorite

Non-infusional 5-Fluorouracil, Doxorubicin and Cisplatin in the Treatment of Locally Advanced or Metastatic Gastro-oesophageal Adenocarcinoma

By Pentheroudakis George   Lim K. Chee   Dunlop David J.   Soukop Mike   Eatock Martin M.  

Acta Oncologica, Vol. 40, Iss. 7, 2001-11 ,pp. : 855-861

Informa Healthcare

Access to resources Recommend Favorite

Phase I Trial of Ifosfamide and 24-h Infusional Paclitaxel in Pelvic Malignancies: A Gynecologic Oncology Group Study

By Markman M.   Spriggs D.   Burger R.A.   Carson L.F.   Lentz S.S.   Gallion H.  

Gynecologic Oncology, Vol. 80, Iss. 3, 2001-03 ,pp. : 359-363

Elsevier

Access to resources Recommend Favorite

"MECCA": A Developmental, Dose-Intensive, Non-Cross-Resistant Platinum-Based Chemotherapy for Advanced Ovarian Cancer

By Hoskins P.J.   Swenerton K.D.   Pike J.A.   Mcmurtrie E.M.   Lee N.  

Gynecologic Oncology, Vol. 63, Iss. 3, 1996-12 ,pp. : 345-351

Academic Press

Access to resources Recommend Favorite

A Phase I Trial of Gemcitabine Administered as a 96-h Continuous Intravenous Infusion in Patients with Advanced Carcinoma and Lymphoma

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 369-376

Humana Press, Inc

Access to resources Recommend Favorite